Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection
NCT04438694
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
67
Enrollment
OTHER
Sponsor class
Conditions
COVID19
Interventions
BIOLOGICAL:
Convalescent Plasma
DRUG:
Standard of Care
Sponsor
Cairo University